Utility of specific laboratory biomarkers to predict severe sepsis in pediatric patients with SIRS

Shannon Byler1, Alexandra Baker2, Eli Freiman2

  • 1Boston Combined Residency Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States of America.

Insights

Common lab tests like CRP, ESR, lactic acid, and procalcitonin are specific but not sensitive for identifying severe sepsis in children with SIRS. These biomarkers can help identify severe sepsis but may miss some cases.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Pathology
  • Infectious Diseases

Background:

  • Systemic inflammatory response syndrome (SIRS) is a common presentation in pediatric emergency departments.
  • Early identification of severe sepsis is crucial for improving patient outcomes.
  • Readily available laboratory biomarkers are often used to aid in sepsis diagnosis.

Purpose of the Study:

  • To determine the association between common laboratory biomarkers and the development of severe sepsis in children with SIRS.
  • To evaluate the sensitivity and specificity of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), lactic acid, and procalcitonin in predicting severe sepsis.

Main Methods:

  • Retrospective cohort study analyzing emergency department encounters with sepsis alerts.
  • Included patients with SIRS criteria and available CRP, ESR, lactic acid, or procalcitonin levels within 6 hours of arrival.
  • Used receiver operating characteristic (ROC) curves to assess biomarker performance for severe sepsis and culture-positive sepsis.

Main Results:

  • Procalcitonin showed the highest area under the curve (AUC) for severe sepsis (0.62).
  • ESR (0.68) and CRP (0.67) had the highest AUC for culture-positive sepsis.
  • At 90% sensitivity, biomarker thresholds were within normal ranges; at 90% specificity, thresholds were identified for each biomarker.

Conclusions:

  • Elevated CRP, ESR, lactic acid, and procalcitonin are specific but not sensitive indicators for severe sepsis in pediatric SIRS patients.
  • These biomarkers can aid in identifying severe sepsis but may not detect all cases, highlighting the need for clinical assessment.
Abstract